AgomAb Therapeutics N.V. American Depositary Shares

NASDAQ:AGMB

Biotechnology

Healthcare
$5.82 +2.48%

+$0.25 today

Market cap
$286.62M
Beta
2.62
P/E (TTM)
-7.1
EPS (TTM)
-$1.28
52W Low $8.75High $17.45

Volume 0.13M

Average 0.14M

AGMB Other Current Liabilities

Short-term obligations not reported separately, such as accrued expenses.

AgomAb Therapeutics N.V. American Depositary SharesNASDAQ: AGMB

Other Current Liabilities · Q3 FY2025 · quarter ended Sep 2025

Other current liabilities of €0 in Q3 FY2025

Q3 FY2025 other current liabilities was €0.

Context

  • Other current liabilities amounted to 0.0% of total assets at the end of Q3 FY2025.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterSep 2025
€0— QoQ
Other Current Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Current Liabilities history

Currency unavailable · from the balance sheet

No Other Current Liabilities data reported for this period type.

Other Current Liabilities vs competitors

How AGMB compares with its peers on the latest reported figures

  • Peers report in different currencies, so other current liabilities is compared through growth and share of total assets rather than absolute size.
  • Other current liabilities amounts to 0.0% of total assets for AGMB, versus a peer median of 5.5%.
AGMB Competitors
Other Current Liabilities for AGMB and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ALMSAlumis Inc. Common StockJun 2026$51.94M USD+304.3%+151.8%9.3%
ANABAnaptysBio, Inc.Mar 2026$26.53M USD+408.5%+27.3%8.0%
ACRSAclaris Therapeutics, Inc.Mar 2026$6.06M USD-39.9%-8.8%3.0%
EQEquillium, Inc.Mar 2026$1.13M USD-49.7%—1.8%
AGMBAgomAb Therapeutics N.V. American Depositary SharesSep 2025€0 EUR——0.0%
ODTXOdyssey Therapeutics, Inc.—— ———
Peer median (excluding AGMB) —+132.2%+27.3%5.5%

Competitors are the stored peer set for AGMB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

AgomAb Therapeutics N.V. American Depositary Shares

NASDAQ:AGMB

Intrinsic Alpha fair value

Locked

Current Price

$5.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.